The indications of endoscopic management for chronic pancreatitis are strictly related to the classification of severe types and to the particular anatomy of the ducts. (1) Impacted or distal calculi without stricture: ESWL followed by EPS and extraction of fragments. (2) Stone(s) and stricture: ESWL, EPS, NPC, and then 10-french plastic stenting. (3) Relapsing strictures (with upward dilatation) after 6-12 months’ stenting: coated self-expanding stent (in a prospective trial), versus surgical laterolateral pancreaticojejunostomy (Partington-Ro-chelle operation). (4) Paraduodenal cyst bulging into the duodenum: ECD ± stenting. (5) Retrogastric pseudocyst: ECG and stenting. (6) Jaundice and/or cholestasis due to stricture of the intrapancreatic CBD: 10-french single or multiple plastic stents for calibration during 3 months. For relapsing cholestasis and stricture, 30-french metal mesh stent versus surgical hepaticojejunostomy. Due to the tremendous variations of the ducts’ anatomy, the method includes drainage through the minor papilla for patients with a dominant Santorini or dorsal duct (table 6). The indications of endoscopic management for chronic pancreatitis are specific and require complete imaging and functional check-up (ERCP, CT scanner, endosonography, pancreatic function tests). The technique is quite difficult and requires high-definition fluoroscopy, appropriate devices and experienced gastrointestinal assistents and radiologists. On these conditions, the complication rate is very low and can usually be medically controlled. Treatment does not compromise any further surgery. Endoscopy makes it possible to avoid or to postpone surgery, the indication for which might become better defined and the patients more carefully selected in the fu